At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint research program to create an AI-based pathology diagnostic tool at the 20th annual ...

Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...

A new study that analyzed protein levels in 2,002 primary tumors from 14 tissue-based cancer types identified 11 distinct molecular subtypes, providing systematic knowledge that greatly expands a ...

Scientists from Skoltech and Sechenov University have developed an approach for diagnosing chronic kidney disease in its early stages. It relies on a urine sample, analyzing protein content to find ...

A UB researcher has been awarded a National Heart, Lung and Blood Institute grant to explore how changes in arterial stiffness elicit vascular smooth muscle cell (VSMC) behaviors that contribute to ...

A wise medical precept is attributed to Theodore Woodward, MD (1914-2005): "When you hear hoofbeats, think of horses, not zebras." Primary care pediatricians, however, often find themselves ...